...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this
Issued in connection with Plan of Arrangement  April 30, 2013 = 75,202,620 shares
Balance, Sept 27, 2023, 152,219,369 
Dilution just over 200%
Shares got doubled.
 
Koo

 

Share
New Message
Please login to post a reply